Signature Wealth Management Partners’s TG Therapeutics TGTX Stock Holding History

Signature Wealth Management Partners’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$647K	Hold	11,780	–	–	0.3%	60
2026 Q1	$391K	Buy	11,780 +1,000	+9%	+$29.8K	0.2%	80
2025 Q4	$321K	Sell	10,780 -400	-4%	-$13.1K	0.16%	87
2025 Q3	$404K	Buy	11,180 +400	+4%	+$13.2K	0.21%	75
2025 Q2	$388K	Hold	10,780	–	–	0.22%	70
2025 Q1	$425K	Hold	10,780	–	–	0.28%	64
2024 Q4	$324K	Hold	10,780	–	–	0.22%	77
2024 Q3	$252K	Hold	10,780	–	–	0.18%	87
2024 Q2	$192K	Hold	10,780	–	–	0.15%	101
2024 Q1	$164K	Hold	10,780	–	–	0.13%	99
2023 Q4	$184K	Buy	+10,780	New	+$125K	0.16%	93
2023 Q3	–	Sell	-8,410	Closed	-$209K	–	100
2023 Q2	$209K	Buy	+8,410	New	+$217K	0.19%	92
2021 Q2	–	Sell	-4,330	Closed	-$209K	–	110
2021 Q1	$209K	Buy	+4,330	New	+$208K	0.2%	96

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Signature Wealth Management Partners's TGTX Position: Q2 2026 in Review

Signature Wealth Management Partners held its TG Therapeutics (TGTX) position steady in Q2 2026 at 11,780 shares worth $647K. The position accounts for 0.3% of the portfolio, ranked #60.

Signature Wealth Management Partners first reported a position in TGTX in Q1 2021 and has held it in 13 quarters since. 205 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Signature Wealth Management Partners held 11,780 shares of TG Therapeutics worth $647K as of Q2 2026.
Signature Wealth Management Partners left its TG Therapeutics share count unchanged in Q2 2026.
TG Therapeutics made up 0.3% of Signature Wealth Management Partners's portfolio in Q2 2026, its #60 holding.
Signature Wealth Management Partners first reported a position in TG Therapeutics in Q1 2021 and has held it in 13 quarters since.
205 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Signature Wealth Management Partners's 13F filing for Q2 2026, filed 29 Jul 2026.